Natera
Showing 1 - 25 of 64
Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Active, not recruiting
- Melanoma
-
Murray, Utah
- +1 more
Feb 17, 2023
ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- SIGNATERA™ ctDNA testing
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 26, 2022
Carcinoma, Hepatocellular, Liver Cell Carcinoma Trial in New Brunswick (Tislelizumab)
Recruiting
- Carcinoma, Hepatocellular
- Liver Cell Carcinoma
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
ctDNA Assay in Patients With Resectable Pancreatic Cancer
Recruiting
- Pancreas Cancer
-
Oklahoma City, OklahomaUniversity of Oklahoma
Jun 10, 2022
Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- ctDNA Blood Test
- +8 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University
Feb 8, 2023
Heart Transplant Rejection Trial in San Carlos
Recruiting
- Heart Transplant Rejection
-
San Carlos, CaliforniaNatera
Jan 11, 2022
Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)
Recruiting
- Melanoma (Skin)
- Melanoma, Uveal
-
Oxford, United KingdomChurchill Hospital, Oxford University Hospitals NHS Trust
Jul 28, 2022
Microvascular Disease as Assessed by PET and Graft Injury by
Not yet recruiting
- Cardiac Allograft Vasculopathy
- +2 more
- Blood draw to measure the levels of dd-cf DNA
-
New Haven, ConnecticutYale New Haven Health
Mar 6, 2023
Solid Tumor Trial in Singapore (CURATE.AI, Nivolumab)
Recruiting
- Solid Tumor
- CURATE.AI
- Nivolumab
-
Singapore, SingaporeNational University Hospital
Jun 29, 2022
Trifecta-Lung cfDNA-MMDx Study
Recruiting
- Lung Transplantation
-
Melbourne, Australia
- +5 more
Apr 18, 2023
Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Washington (Atezolizumab, Bevacizumab)
Not yet recruiting
- Colon Adenocarcinoma
- +6 more
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Jul 28, 2022
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023
Metastatic Colorectal Cancer Trial in Gainesville (Signatera ctDNA assay, pre-specified sequence of FDA-approved drugs and drug
Recruiting
- Metastatic Colorectal Cancer
- Signatera ctDNA assay
- pre-specified sequence of FDA-approved drugs and drug combinations
-
Gainesville, FloridaUniversity of Florida
Aug 9, 2022
Stage III Colon Cancer Trial in Pittsburgh (Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month)
Recruiting
- Stage III Colon Cancer
- Signatera test
- +5 more
-
Pittsburgh, PennsylvaniaNRG Oncology - Pittsburgh Center
Mar 30, 2022
Colon Adenocarcinoma, Colorectal Cancer Trial in Orange (drug, combination product, diagnostic test)
Recruiting
- Colon Adenocarcinoma
- Colorectal Cancer
- TAS-102
- +3 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
May 24, 2022
Improve Organ Preserving Strategies in Rectal Cancer
Recruiting
- Rectal Adenocarcinoma
- +8 more
- Biopsy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 30, 2022
BESPOKE Study of ctDNA Guided Immunotherapy
Recruiting
- Colorectal Cancer
- +2 more
-
San Carlos, CaliforniaNatera
Sep 10, 2021
Breast Cancer Trial in London (ctDNA)
Not yet recruiting
- Breast Cancer
- ctDNA
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Sep 17, 2021
Breast Cancer, Prostate Cancer, Colorectal Cancer Trial in United States (Exercise)
Recruiting
- Breast Cancer
- +11 more
- Exercise
-
San Carlos, California
- +7 more
Aug 24, 2022
Trifecta-Heart cfDNA-MMDx Study
Recruiting
- Heart Transplant Rejection
- MMDx diagnostic test
- +2 more
-
Los Angeles, California
- +9 more
Aug 2, 2022
Transplant;Failure,Kidney Trial in San Francisco (Natera KidneyScan, Clinical Performance and Value Vignettes)
Completed
- Transplant;Failure,Kidney
- Natera KidneyScan
- Clinical Performance and Value Vignettes
-
San Francisco, CaliforniaQURE Healthcare
Sep 14, 2020
Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)
Not yet recruiting
- Gastrooesophageal Cancer
- Trastuzumab deruxtecan
-
Southampton, Hampshire, United Kingdom
- +16 more
Jul 27, 2023
Active Rejection in Organs Using Donor-derived Cell-free DNA
Recruiting
- Kidney Transplant Rejection
- +2 more
-
San Carlos, California
- +1 more
Jan 27, 2021
Natera Ovarian Cancer Detection Assay
Terminated
- Adnexal Mass
-
Pittsburgh, PennsylvaniaMagee-Women's Hospital of UPMC
Feb 4, 2020